Details of the Acquisition

Target Company: Ampin C&I Power Twelve Private Limited (CIN: U35105DL2025PTC447012), incorporated on April 23, 2025. Registered office at 309, 3rd Floor Rectangle One, Behind Sheraton Hotel, Saket, Saket (South Delhi), Delhi, India, 110017.

Financial Snapshot of AMPIN (as of 31.03.2026):

  • Net Worth: ₹120.78 million
  • Standalone Turnover for FY 2025-26: Nil
  • Profit After Tax for FY 2025-26: ₹(1.28) million (Loss)

Investment Details:

  • Date of Investment: June 10, 2026
  • Consideration: Cash payment of ₹5,47,60,000 (Rupees Five Crores Forty Seven Lakhs Sixty Thousand only)
  • Shares Acquired: 54,76,000 equity shares of face value ₹10 each, subscribed at par

Shareholding Impact:

  • Post-investment, Biocon will hold 59,76,000 equity shares in AMPIN.
  • This represents 37.77% of AMPIN's paid-up share capital on an undiluted basis as of the date of the disclosure.
  • The holding is expected to be diluted to 15.91% on a fully diluted basis following future investments by other entities, as per the terms of the Share Purchase, Subscription and Shareholders Agreement.

Strategic Rationale and Objects

  • The acquisition is part of a Power Purchase Agreement and Shareholders Agreement to maintain captive status as required by the Electricity Act.
  • Purpose: To enhance renewable-based power consumption, support the procurement of green energy, and advance the company's decarbonization goals.
  • Expected Impact: Reduction in energy costs and carbon footprint for Biocon Limited.

Regulatory and Transactional Details

  • Related Party Transaction: The acquisition is not a related party transaction. The promoter and promoter group of Biocon have no interest in AMPIN.
  • Government Approvals: Not applicable as per the disclosure.
  • Industry Classification: AMPIN operates in the Renewable Energy Generation sector.
  • Business of AMPIN: The company is setting up a Solar Power Plant with a capacity of 27.12 MW (DC) in the state of Karnataka.

Additional Information

  • The allotment of the subscribed shares is expected to take place "in due course."
  • The disclosure was made via a letter signed by Rajesh U. Shanoy, Company Secretary and Compliance Officer (ICSI Membership Number: A16328), on June 10, 2026.

#Biocon #Ampin #SEBIRegulation30 #RenewableEnergy #M&A